NCT02751450View on ClinicalTrials.gov

The Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity(DH)

NACompletedINTERVENTIONAL
Enrollment

263

Participants

Timeline

Start Date

February 1, 2016

Primary Completion Date

May 1, 2016

Study Completion Date

June 17, 2016

Conditions
Dentin Sensitivity
Interventions
DEVICE

Stannous Fluoride dentifice

Experimental dentifrice containing 0.454% w/w stannous fluoride (1100ppm)

OTHER

Sodium Monofluorophosphate dentifrice

Dentifrice containing 0.76% sodium monofluorophosphate (1000ppm fluoride)

Trial Locations (1)

BS1 2LY

GSK Investigational Site, Bristol

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY